Stock Focus: Highlights of HCL Tech, DMart, IREDA, Piramal Pharma, Lupin on Monday – HeadlineFly

Image for: Stock Focus: Highlights of HCL Tech, DMart, IREDA, Piramal Pharma, Lupin on Monday - HeadlineFly

📷 Image Credits: Moneycontrol

On Monday, the stock market will be buzzing with the latest updates on various companies, including HCL Technologies, DMart, IREDA, Piramal Pharma, and Lupin. These companies have made significant strides in their respective industries, impacting the stock market in India.

HCL Technologies reported a 6.8% rise in net profit to Rs 4,257 crore for the quarter, with a slight drop in revenue. Despite the decrease, the company is optimistic about achieving a 3-5% revenue growth in FY25. DMart also saw a strong performance, with a 17.5% increase in net profit and an 18.6% jump in revenue in Q1.

IREDA, the Indian Renewable Energy Development Agency, experienced a 30.2% spike in net profit and a significant increase in net interest income. Additionally, 5paisa Capital, Bhansali Engineering Polymers, and Plastiblends India showcased positive growth in their financial results for the quarter.

Lupin, a global pharmaceutical company, received a positive Establishment Inspection Report from the US FDA for its manufacturing facility in Gujarat. Similarly, Piramal Pharma’s PPDS Ahmedabad facility passed the Pre-Approval Inspection with flying colors. Marico, Rail Vikas Nigam, and Jupiter Wagons also had notable updates, further adding to the excitement in the stock market.

Overall, these companies are driving momentum in the business sector in India, with promising results and significant developments in their respective fields.